Energy dissipation via UCP1 of BAT potentially enhances the total energy expenditure of the whole body up to 20% [4]; therefore, UCP1 activation is considered a potentially promising therapeutic approach for obesity and diabetes treatment [5]. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.